I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
A screen of FDA-approved drugs with minigenome identified t..:
Hirano, Minato
;
Sakurai, Yasuteru
;
Urata, Shuzo
...
Antiviral Research. 200 (2022) - p. 105276 , 2022
Link:
https://doi.org/10.1016/j.antiviral.2022.105276
RT Journal T1
A screen of FDA-approved drugs with minigenome identified tigecycline as an antiviral targeting nucleoprotein of Crimean-Congo hemorrhagic fever virus
UL https://suche.suub.uni-bremen.de/peid=cr-10.1016_j.antiviral.2022.105276&Exemplar=1&LAN=DE A1 Hirano, Minato A1 Sakurai, Yasuteru A1 Urata, Shuzo A1 Kurosaki, Yohei A1 Yasuda, Jiro A1 Yoshii, Kentaro PB Elsevier BV YR 2022 SN 0166-3542 JF Antiviral Research VO 200 SP 105276 LK http://dx.doi.org/https://doi.org/10.1016/j.antiviral.2022.105276 DO https://doi.org/10.1016/j.antiviral.2022.105276 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)